Efficacy and safety of traditional Chinese medicine in the treatment of menopause-like syndrome for breast cancer survivors: a systematic review and meta-analysis

被引:0
作者
Runxi Wang
Yan Wang
Liyuan Fang
Yi Xie
Shuhan Yang
Suying Liu
Yuhang Fang
Ying Zhang
机构
[1] China Academy of Chinese Medical Sciences,Department of Oncology, Guang’anmen Hospital
[2] Beijing University of Chinese Medicine,undefined
来源
BMC Cancer | / 24卷
关键词
Breast cancer; Endocrine therapy; Menopause-like syndrome; Systematic review; meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 106 条
[1]  
Harbeck N(2021)Guidelines and Guidelines for Diagnosis and Treatment of Breast Cancer of the Chinese Anticancer Association Chinese J Cancer. 31.10 954-1040
[2]  
Gnant M(2017)Breast cancer Lancet. 389 1134-1150
[3]  
Rees M(2020)European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after breast cancer: focus on menopausal symptoms and osteoporosis Maturitas. 134 56-61
[4]  
Angioli R(2019)The effects of adjuvant endocrine therapy on bone health in women with breast cancer J Endocrinol. 241 R111-R124
[5]  
Coleman RL(2019)miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer J Exp Clin Cancer Res. 38 22-661
[6]  
Glasspool R(2016)Natural products as sources of new drugs from 1981 to 2014 J Nat Prod. 79 629-508
[7]  
Plotti F(2021)A natural product, piperlongumine (PL), increases tumor cells sensitivity to NK cell killing Int Immunopharmacol. 96 658-915
[8]  
Simoncini T(2020)Natural products and their derivatives: promising modulators of tumor immunotherapy J Leukoc Biol. 108 493-84
[9]  
Ramchand SK(2021)Natural compounds as metabolic modulators of the tumor microenvironment Molecules. 26 3494-333
[10]  
Cheung YM(2019)Polyphenols as immunomodulatory compounds in the tumor microenvironment: friends or foes? Int J Mol Sci. 20 1714-247